reports
MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new...
MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member April 2, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Carla Goulart Peron, MD, Chief Medical Officer at Philips, has been appointed to the of the Medical Device Innovation Consortium (). Founded in 2012, MDIC is a unique public-private partnership that brings stakeholders across the medical device spectrum together with the US Food and Drug Administration () and other agency partners to help ensure patient access to medical device inn...
FDA clears Philips AI solution that provides real-time guidance during...
FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair March 26, 2026 Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive procedures, supporting treatment [2]DeviceGuide integrates with Philips Azurion image-guided therapy platform that combines imaging, real-time data and intelligent software within a unified workflow to support more consistent, efficient and confidently guided minimally invasive procedures Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA...
Philips launches IntraSight Plus to simplify coronary interventions an...
Philips launches IntraSight Plus to simplify coronary interventions and advance precision care March 25, 2026 Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient careWith FDA clearance and CE marking, IntraSight Plus streamlines the workflow efficiency of minimally invasive coronary procedures and can enable system operation time savings up to 47% in both the USA and Europe Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technolog...
Philips remains No. 1 in Medtech at European Patent Office and the lar...
Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant March 24, 2026 Philips ranks No. 1 among medical technology companies in the European Patent Office Technology Dashboard 2025, filing 1,289 patent applications with the EPO in 2025.Philips’ platform-based solutions integrate hardware, software, data and AI to address clinical, operational and everyday health challenges.Philips’ innovation improved the lives of 2 billion people in 2025, with the goal of improving 2.5 billion lives per year by 2030, including 400 million people in medically unde...
Philips convenes the Annual General Meeting of Shareholders 2026
Philips convenes the Annual General Meeting of Shareholders 2026 March 23, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposal to appoint John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026.Proposals to re-appoint Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as m...
Philips proposes new appointment and re-appointments to its Supervisor...
Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment March 23, 2026 John DeFord proposed as new member of the Supervisory Board.Paul Stoffels, Herna Verhagen and Sanjay Poonen proposed for re-appointment as members of the Supervisory Board.Marc Harrison will step down from Philips’ Supervisory Board after his second term.Roy Jakobs proposed for re-appointment as President/CEO and Chairman and member of the Board of Management, as previously announced. Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology,...
- Luis Arredondo
ALMIRALL: VEMOS RECORRIDO CON EL CUMPLIMIENTO DE SUS GUÍAS (ANÁLISIS B...
Vemos recorrido con el cumplimiento de sus guías. SOBREPONDERAR. Tras los Rdos.4T’25, revisamos estimaciones un +5% en EBITDA promedio’26-28e para ajustarnos a su guidance’26e (EBITDA entre 270/290 M euros; +20% vs 2025) y hacemos roll over, con un impacto conjunto de +16% en nuestro P.O. hasta 14,50 euros/acc. (+27% potencial). En nuestra opinión, ALM ofrece un perfil defensivo en el entorno de volatilidad actual y tras su mal performance reciente (-11% en 2026; -11% vs IBEX) vemos margen de re...
- Research Department
IBERIAN DAILY 18 MARCH (ANÁLISIS BANCO SABADELL)
NEWS SUMMARY: ALMIRALL, PUIG BRANDS. The Ibex returns to 17,200 points Yesterday Brent crude remained above US$ 100/b for the fourth session, with stock markets seeing gains for the second consecutive session, where Israel confirmed the death of Iran’s national security chief, A. Larijani. In the STOXX 600, most sectors ended with gains, led by Energy (for the second consecutive session) and Utilities vs. the drops of Media an Consumer Goods On the macro side, in Germany March’s ZEW index slow...
- Research Department
INFORME DIARIO 18 MARZO (ANÁLISIS BANCO SABADELL)
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ALMIRALL, PUIG BRANDS. El Ibex recupera los 17.200 puntos Ayer fue la cuarta jornada con el precio del Brent por encima de 100 dólares y la segunda sesión consecutiva al alza de las bolsas en el día que Israel confirmaba la muerte del jefe de la seguridad nacional iraní A. Larijani. En el STOXX 600, la mayoría de sectores cerraron con ganancias, lideradas por Energía (por segundo día consecutivo) y Utilites frente a las caídas de Media y B. de Con...
- Research Department
IBERIAN DAILY 17 MARCH (ANÁLISIS BANCO SABADELL)
NEWS SUMMARY: ALMIRALL, ELECTRICITY SECTOR, INDRA. Oil prices set the pace Stock markets kicked off the week with gains, underpinned by the fall in oil prices due to the potential extension of reserves freed in developed countries, Trump’s attempt to boost an international coalition to reopen the Strait of Hormuz and allow some ships to pass through. In the STOXX 600, all sectors with the exception of Autos, Media and Chemicals saw gains, led by Real Estate and Energy. On the macro side, in th...
- Research Department
INFORME DIARIO 17 MARZO (ANÁLISIS BANCO SABADELL)
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ALMIRALL, INDRA. EUROPA: BNP PARIBAS, SECTOR ELÉCTRICO, UNICREDIT. El petróleo marca la pauta La semana arrancó con avances de las bolsas apoyados en el retroceso del petróleo, favorecido por la potencial ampliación de las liberaciones de reservas en países desarrollados, el intento de Trump de impulsar una coalición internacional para reabrir el Estrecho de Ormuz y el paso puntual de algunos buques. En el STOXX 600, todos los sectores menos Autos,...
- Research Department
INFORME DIARIO 13 MARZO (ANÁLISIS BANCO SABADELL)
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: BBVA, IAG, TELEFÓNICA. El crudo y las dudas en crédito privado lastran la confianza en las bolsas Aumentan las caídas en los índices europeos, con el S&P 500 jugándose el soporte de los 6.700 puntos. El Euro STOXX 50 tocó la referencia de los 5.750 puntos por las tensiones en Medio Oriente (el Brent volvió a los 99 d/b) y las preocupaciones sobre el crédito privado. En el STOXX 600, los mejores sectores fueron Químicas y Utilities mientras que Via...
- Research Department
IBERIAN DAILY 13 MARCH (ANÁLISIS BANCO SABADELL)
NEWS SUMMARY: BBVA, IAG, TELEFÓNICA. Crude oil and private credit drag down stock market confidence European stock markets fell further, with the S&P 500 on the verge of falling below the 6,700 point support. The Euro STOXX 50 hit 5,750 due to the tension in the Middle East (Brent returned to US$ 99/barrel) and the concerns on private credit. In the STOXX 600, the best-performing sectors were Chemicals and Utilities, whereas Travel & Leisure and Banks suffered the biggest corrections. On the m...
Philips expands digital pathology portfolio with cloud-enabled Philips...
Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite March 11, 2026 Fully cloud‑enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Amsterdam, The Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its digital pathology portfolio with new cloud-enabled capabilities designed to help healthcare organizations scale digital diagnostics, improve productivity, and advance their transformation to fully digital workflows....
Philips connects patient monitoring and diagnostics to advance platfor...
Philips connects patient monitoring and diagnostics to advance platform-based care intelligence at HIMSS26 March 10, 2026 Amsterdam, the Netherlands, and Las Vegas, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how open, interoperable, AI-enabled platforms can help health systems connect continuous patient monitoring with diagnostic insights – bringing the patient story together across time and across specialties. By connecting clinical signals with diagnostic information, Philips enables care teams to move from fragmented data to a more continuous,...
- Marc Hesselink
- CFA
Philips/Execution is key/HOLD
Philips reported a better-than-expected 4Q25 update and a supportive CMD message. We increase our estimates, raise our target price from €23 to €26 and reiterate our Hold rating. Philips appears positioned to continue progressing operationally, but we believe consistent delivery will be required before we see meaningful outperformance versus the sector. Valuation at 15x adj EPS 2027F is in line with peers.
Philips unveils Rembra CT at ECR 2026, setting a new benchmark for spe...
Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments March 4, 2026 CE Marked and 510(k) pending, Rembra’s advanced image reconstruction technology delivers up to 106 images per second [1] and a high throughput of up to 270 patients per day [2] to support faster diagnosis by making scans available in near-real timeWith the largest-in-class 85 cm bore, Rembra accommodates challenging patient types, providing more access for complex interventions, bariatric imaging a...
- Research Department
IBERIAN DAILY 02 MARCH (ANÁLISIS BANCO SABADELL)
NEWS SUMMARY: AMADEUS, AMPER, CAF, IBERDROLA, REDEIA, TALGO, TELEFÓNICA, UNICAJA. We begin a highly volatile week European stock markets ended last week with corrections whereas doubts persist in the technology sector and the geopolitical tension between the US and Iran continues. The Ibex endured battery of earnings and ended above 18,000 points. In the STOXX 600, the best-performing sectors last week were Utilities and Real Estate, whereas Basic Materials and Telecoms had the biggest drops....
- Research Department
INFORME DIARIO 02 MARZO + RDOS. EUROPA. PREVIEWS (ANÁLISIS BANCO SABAD...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: AMADEUS, AMPER, CAF, IBERDROLA, REDEIA, TALGO, TELEFÓNICA, UNICAJA. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’25 que se publicarán en España y Europa en los próximos días. Empezamos una semana de elevada volatilidad Las bolsas europeas cerraron la semana con pérdidas, mientras persisten las dudas e...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.